Home

Explore our programme tracks

Recent global disease events, like the outbreaks of Ebola, MERS and Zika, have underpinned the increasing impact of zoonotic diseases on human and animal health.

It has also become clear that changes in the environment, like population growth and climate change, are drivers for the emergence of such zoonoses. The 5th International One Health Congress will therefore carefully evaluate the most imminent potential hazards from various perspectives.

“One Health aims to prevent disease at a very high level, it addresses the root causes of what is driving diseases to emerge.”

Laura H. Kahn from Princeton University, USA

Important topics

Wildlife trade as a mechanism for exotic disease spill overs

Food safety and security

Rabies virus: treatment protocols and control measures

Vaccine development and new testing platforms

Mathematical modelling and scenario evaluation

Tackling coronaviruses at the source: vaccinating camels and humans against MERS

In September 2016, the World Health Organization officially stated that “antimicrobial resistance is a global societal challenge and threat”.

Antimicrobial resistance had emerged as a health issue in the last decades, but only in the last couple of years has there been an understanding that we are facing a post-antibiotic era, in which common infections and minor injuries, which have been treatable for decades, can once again kill. Misuse and overuse in high levels of antibiotics in both human health and agriculture are at the basis of the emergence of AMR. Whilst raising awareness of AMR is an important issue, new antibiotics urgently need to be developed. The organizers of the 5th International One Health Congress share WHO’s concern and will investigate pathways to overcome the challenges posed upon us by AMR in a separate programme track. In seven sessions, world experts will elaborate on the use of antibiotics and the surge in antimicrobial resistance in food animals and humans, and scan the horizon for new antibiotics and antivirals.

The emergence of AMR really threatens to send us backwards. By 2050 more people will die from antibiotic-resistant infections than currently die from cancer.

Dr Keiji Fukuda, Assistant Director-General of the World Health Organization

The Science Policy Interface track is a tailor-made programme for public health officials and government representatives.

The Science Policy Interface (or SPI) was first introduced at the 3rd International One Health Congress in Amsterdam and has proven a successful concept to integrate science and health policy as it offers information and practical application based on the most recent scientific insights. To that end, the world’s leading experts will ‘translate’ the newest scientific data into daily policy practice, focusing on topics such as neglected infectious diseases, (re-)emerging infectious diseases, antimicrobial resistance, and scientific and societal intervention strategies. The target audience of the science policy interface includes Chief Veterinary Officers, Chief Medical Officers, Director-Generals of Public Health, representatives of national and international public health organizations, and pharmaceutical industry policy experts.

“Some of the most devastating new human infections, like Ebola, HIV and dengue, have naturally transmitted from animals to humans. Health scientists and public health officials therefore need to work together to attain optimal health for people, animals, and our environment. The Science Policy Interface programme at the 5th International One Health Congress offers an excellent platform for such interaction.”

Recent global disease events, like the outbreaks of Ebola, MERS and Zika, have underpinned the increasing impact of zoonotic diseases on human and animal health.

It has also become clear that changes in the environment, like population growth and climate change, are drivers for the emergence of such zoonoses. The 5th International One Health Congress will therefore carefully evaluate the most imminent potential hazards from various perspectives.

“One Health aims to prevent disease at a very high level, it addresses the root causes of what is driving diseases to emerge.”

Laura H. Kahn from Princeton University, USA

Important topics

Wildlife trade as a mechanism for exotic disease spill overs

Food safety and security

Rabies virus: treatment protocols and control measures

Vaccine development and new testing platforms

Mathematical modelling and scenario evaluation

Tackling coronaviruses at the source: vaccinating camels and humans against MERS

In September 2016, the World Health Organization officially stated that “antimicrobial resistance is a global societal challenge and threat”.

Antimicrobial resistance had emerged as a health issue in the last decades, but only in the last couple of years has there been an understanding that we are facing a post-antibiotic era, in which common infections and minor injuries, which have been treatable for decades, can once again kill. Misuse and overuse in high levels of antibiotics in both human health and agriculture are at the basis of the emergence of AMR. Whilst raising awareness of AMR is an important issue, new antibiotics urgently need to be developed. The organizers of the 5th International One Health Congress share WHO’s concern and will investigate pathways to overcome the challenges posed upon us by AMR in a separate programme track. In seven sessions, world experts will elaborate on the use of antibiotics and the surge in antimicrobial resistance in food animals and humans, and scan the horizon for new antibiotics and antivirals.

The emergence of AMR really threatens to send us backwards. By 2050 more people will die from antibiotic-resistant infections than currently die from cancer.

Dr Keiji Fukuda, Assistant Director-General of the World Health Organization

The Science Policy Interface track is a tailor-made programme for public health officials and government representatives.

The Science Policy Interface (or SPI) was first introduced at the 3rd International One Health Congress in Amsterdam and has proven a successful concept to integrate science and health policy as it offers information and practical application based on the most recent scientific insights. To that end, the world’s leading experts will ‘translate’ the newest scientific data into daily policy practice, focusing on topics such as neglected infectious diseases, (re-)emerging infectious diseases, antimicrobial resistance, and scientific and societal intervention strategies. The target audience of the science policy interface includes Chief Veterinary Officers, Chief Medical Officers, Director-Generals of Public Health, representatives of national and international public health organizations, and pharmaceutical industry policy experts.

“Some of the most devastating new human infections, like Ebola, HIV and dengue, have naturally transmitted from animals to humans. Health scientists and public health officials therefore need to work together to attain optimal health for people, animals, and our environment. The Science Policy Interface programme at the 5th International One Health Congress offers an excellent platform for such interaction.”

Free registration for members of the press

Members of the press can have their congress registration fee waived. They just need to send a copy of their press accreditation to the congress press manager, Mr. David De Pooter, at [email protected] to receive further instructions.

One Health Fellowship Fund

The One Health Platform actively encourages the careers of promising researchers. The conference organizers have therefore established a One Health Fellowship Fund to provide travel grants to young scientists. On 1 December 2017, when the deadline for the submission of fellowship applications expired, no less than 356 early career scientists had submitted an application. Due to the many Fellowship Fund applications we have received, the Review Committee members faced the impossible task of meeting the original deadline of 15 January to announce their results. This deadline has now been postponed to 15 February.

Early career scientists will also act as co-chairs during the scientific conference sessions while the most promising academics may be offered the chance to present their work in a plenary session entirely devoted to the work of promising scientists (Monday 25 June 2018).